---
title: "LifeMD Posts Q1 Results, Reaffirms 2026 Profitability Outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285453881.md"
description: "LifeMD reported Q1 2026 results with revenue of $50.2 million, slightly below last year but above guidance. The adjusted EBITDA loss was $4.5 million, consistent with expectations. Gross margin improved to 88%. Active telehealth subscribers increased by 26% to 365,000. The company reaffirmed its 2026 revenue guidance of $220-$230 million and positive adjusted EBITDA. Analysts rate LFMD stock as a Buy with a $10.00 price target, while TipRanks’ AI Analyst rates it Neutral due to mixed financial performance."
datetime: "2026-05-06T23:22:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285453881.md)
  - [en](https://longbridge.com/en/news/285453881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285453881.md)
---

# LifeMD Posts Q1 Results, Reaffirms 2026 Profitability Outlook

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

LifeMD ( (LFMD) ) has issued an update.

LifeMD reported first-quarter 2026 results on May 6, 2026, with revenue of $50.2 million, slightly below the prior year but above guidance, and an adjusted EBITDA loss of $4.5 million in line with expectations, driven by elevated, front-loaded marketing spend. Gross margin expanded 420 basis points year over year to 88% on favorable product mix and lower fulfillment costs, while the company exited the quarter with $34.5 million in cash, no debt and an undrawn $30 million revolver.

Subscriber metrics underscored LifeMD’s growth strategy, as active telehealth subscribers rose 26% to about 365,000, including record GLP-1 weight management sign-ups and 657% quarter-over-quarter growth in women’s health patients alongside sharply lower acquisition costs. Management highlighted momentum across insurance-supported programs and reaffirmed 2026 guidance for $220 million to $230 million in revenue and positive full-year adjusted EBITDA, signaling confidence that recent investments in weight management and women’s health will translate into stronger profitability in the second half of the year.

The most recent analyst rating on (LFMD) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on LifeMD stock, see the LFMD Stock Forecast page.

**Spark’s Take on LFMD Stock**

According to Spark, TipRanks’ AI Analyst, LFMD is a Neutral.

The score is driven primarily by mixed financial performance (profitability inflection and strong gross margins, but revenue contraction, negative operating profit, and volatile cash flow). Earnings call guidance and operating momentum are supportive, while technicals show strong but potentially overextended near-term momentum and valuation remains weakened by negative earnings and no dividend support.

To see Spark’s full report on LFMD stock, click here.

**More about LifeMD**

LifeMD, Inc. is a U.S.-based provider of virtual primary care, offering telemedicine, lab access, pharmacy services and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management and hormone therapy. The company operates a vertically integrated digital care platform supported by a 50-state affiliated medical group, an affiliated pharmacy and a domestic patient care center, targeting accessible, affordable online healthcare.

**Average Trading Volume:** 1,221,054

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $244.2M

For a thorough assessment of LFMD stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [LFMD.US](https://longbridge.com/en/quote/LFMD.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LFMDP.US](https://longbridge.com/en/quote/LFMDP.US.md)

## Related News & Research

- [LifeMD to Participate in Upcoming Investor Conferences | LFMD Stock News](https://longbridge.com/en/news/286561977.md)
- [LogicMark posts strong Q1 growth, margins and outlook](https://longbridge.com/en/news/286614350.md)
- [DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals | DVA Stock News](https://longbridge.com/en/news/286808813.md)
- [LifeMD Q1 revenue beats estimates on record telehealth subscriber additons](https://longbridge.com/en/news/285436217.md)
- [LifeMD (LFMD) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285449382.md)